PI Industries announces twin acquisitions into Pharma API & CDMO space

Siegfried breaks ground on new R&D center for drug substances in Switzerland

The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth

CCI approves Berhyanda's acquisition of Suven Pharma

The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.

Zydus receives final approval from the USFDA for Metoprolol Tartrate

Metoprolol is used with or without other medications to treat high blood pressure (hypertension).

Jubilant Ingrevia commissions acetic anhydride plant at Bharuch

This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT

Agilent showcases cancer portfolio Solutions at AACR 2023

From cancer research to diagnostic solutions

Advanced library amplification mix delivers superior NGS data quality

NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.

Apitoria Pharma appoints Dr. Sanjay Chaturvedi as CEO

Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023

Dozee Raises $6 million to bolster its ambition of ‘HarBedDozeeBed’

Dozee plans to further tap over 2,000 hospitals in more than 100 districts

Israeli researchers develop an effective drug to prevent muscle diseases

The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.